(S1 (S (NP (NP (NNS PBMCs)) (SBAR (IN from) (S (NP (NN CF) (NNS patients)) (VP (VBP do) (RB not) (VP (VB produce) (NP (NP (VBN increased) (NNS amounts)) (PP (IN of) (NP (NN IL-1beta)))) (PP (IN upon) (NP (NN inflammasome) (NN stimulation))))))))))
(S1 (S (S (NP (JJ Previous) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (NN loss)) (PP (IN of) (NP (NN CFTR)))) (VP (VBZ results) (PP (IN in) (NP (NP (VBN increased) (NN NF-kappaB) (NN activity)) (CC and) (NP (NP (NP (NP (NP (JJ pro-inflammatory) (NN cytokine)) (NN secretion)) (PRN (-LRB- -LSB-) (NP (CD 4)) (-RRB- -RSB-))) (, ,) (NP (NP (NP (-LRB- -LSB-) (CD 5) (-RRB- -RSB-)) (, ,) (NP (-LRB- -LSB-) (CD 32) (-RRB- -RSB-)) (, ,)) (PRN (-LRB- -LSB-) (NP (CD 36)) (-RRB- -RSB-))) (, ,)) (PRN (-LRB- -LSB-) (NP (CD 37)) (-RRB- -RSB-))))))))))) (. .)))
(S1 (S (S (S (VP (TO To) (ADVP (RB further)) (VP (VB examine) (NP (DT this) (NN relationship))))) (, ,) (NP (NP (NNS PBMCs)) (PP (IN from) (NP (NP (NN CF) (NNS patients)) (CC and) (NP (JJ healthy) (JJ adult) (NNS controls))))) (VP (VBD were) (VP (VBN stimulated) (PP (IN with) (NP (NP (NN PAO1)) (, ,) (NP (NN LPS+ATP)) (, ,) (CC and) (NP (NN LPS+Poly-LRB-dA:dT-RRB-)))) (, ,) (S (VP (TO to) (VP (VB activate) (NP (DT the) (NP (NP (NN NLRC4)) (, ,) (NP (NN NLRP3)) (, ,) (CC and) (NP (NN AIM2))) (NNS inflammasomes)) (, ,) (ADVP (RB respectively)))))))) (. .)))
(S1 (S (S (PP (IN By) (NP (NP (CD 24) (NNS hours)) (PP (IN of) (NP (NN stimulation))))) (, ,) (NP (NN CF) (NNS PBMCs)) (VP (VBD did) (RB not) (VP (VB produce) (NP (NP (VBN increased) (NNS amounts)) (PP (IN of) (NP (NP (NP (NN IL-1beta)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 5a)) (-RRB- -RRB-))) (CC or) (NP (NP (NN IL-8)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 5b)) (-RRB- -RRB-)))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (TO to) (NP (JJ healthy) (NNS controls))))))))) (. .)))
(S1 (S (ADVP (RB However)) (, ,) (NP (PRP we)) (VP (VBD did) (NP (NP (NN notice)) (NP (NP (DT a) (JJ transient) (NN decrease)) (PRN (-LRB- -LRB-) (NP (NN P) (JJ <) (CD 0.001)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN IL-1beta))) (VP (VBN produced) (PP (IN by) (NP (NN CF) (NNS cells))) (PP (IN in) (NN response) (TO to) (NP (NN LPS+ATP)))))) (PP (IN at) (NP (CD 6) (NNS hours))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-))) (. .)))
(S1 (S (S (NP (NP (NN Stimulation)) (PP (IN of) (NP (NNS PBMCs))) (PP (IN with) (NP (NP (FW P.) (FW aeruginosa)) (SBAR (WHNP (WDT that)) (S (VP (VBZ lacks) (NP (NP (NP (NN exsA)) (PRN (-LRB- -LRB-) (NP (NN PAO1deltaexsA)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ key) (NN regulator)) (PP (IN of) (NP (NN type) (CD III) (NN secretion)))) (, ,)))))))) (VP (VBD produced) (NP (ADJP (RB three-fold) (JJR less)) (NN IL-1beta)) (PP (VBN compared) (PP (TO to) (NP (NP (DT the) (JJ parental) (NN PAO1) (NN strain)) (PP (IN by) (NP (NP (CD 24) (NNS hours)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 5a)) (-RRB- -RRB-))))))))) (. .)))
(S1 (S (S (NP (NP (NN Inflammasome) (NN stimulation)) (PP (IN without) (NP (NN priming)))) (VP (VBD did) (RB not) (VP (VB result) (PP (IN in) (NP (NP (DT any) (NN IL-1beta) (NN production)) (PP (IN in) (NP (CC either) (NP (NN CF)) (CC or) (NP (JJ control) (NNS PBMCs))))))))) (. .)))
(S1 (S (S (PP (JJ Contrary) (TO to) (NP (PRP$ our) (NN hypothesis))) (, ,) (NP (DT these) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NNS PBMCs)) (PP (IN from) (NP (NN CF) (NNS patients)))) (VP (VP (VBP do) (RB not) (VP (VB display) (NP (NP (VBN increased) (NN production)) (PP (IN of) (NP (NP (NN IL-1beta)) (CC or) (NP (NN IL-8))))) (PP (IN with) (NP (NN inflammasome) (NN activation))))) (CC nor) (VP (VBP do) (S (NP (PRP they)) (VP (VBP suggest) (NP (DT any) (VBN increased) (ADJP (ADJP (JJ basal)) (CC or) (ADJP (JJ induced))) (NN NF-kappaB) (NN activity)))))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (NP (PRP$ our) (NN observation)) (SBAR (IN that) (S (NP (NN caspase-1) (NN activity)) (VP (VBZ is) (RB not) (ADJP (JJ different) (PP (IN between) (NP (NP (NN CF)) (CC and) (NP (NP (JJ control) (NNS PBMCs)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 4)) (-RRB- -RRB-)))))))))))))) (. .)))
